News|Articles|December 9, 2024
Beyond Abstinence: Other Clinically Meaningful Endpoints for Patients With Substance Use Disorders
Author(s)F. Gerard Moeller, MD
Key Takeaways
- Complete abstinence is not the only meaningful endpoint for substance use disorder patients; reduction in use can save lives.
- The session explores alternative endpoints like impulsivity, compulsive behaviors, and craving in clinical trials.
While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!
Advertisement
F. Gerard Moeller, MD, shares more on his session "
His take home message: Complete abstinence is not the only clinically meaningful endpoint for patient with substance use disorders. A reduction of use in fentanyl, for example, good result in saving lives.
The varied presenters of this session cover reduction in use, impulsivity, compulsive behaviors, craving, and more.
Are you attending this year's ACNP meeting? Let us know at
Dr Moeller is a professor in the Department of Pharmacology and Toxicology at Virginia Commonwealth University.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
2
Preliminary Report on Dangers of AI Chatbots
3
Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
